Therapeutic Vaccine Strategies against Human Papillomavirus.
about
The use of urine in the follow-up of HPV vaccine trials.Immunizing against Anogenital Cancer: HPV VaccinesGTL001, a bivalent therapeutic vaccine against human papillomavirus 16 and 18, induces antigen-specific CD8+ T cell responses leading to tumor regression.Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumoursCurrent therapeutic vaccination and immunotherapy strategies for HPV-related diseases.Biomarkers in anal cancer: from biological understanding to stratified treatment.Multiple preinvasive and invasive HPV-related lesions of the anogenital tract in a female patient with HIV infection: A case report.Reverse Vaccinology: The Pathway from Genomes and Epitope Predictions to Tailored Recombinant Vaccines.Current status and future prospects for human papillomavirus vaccines.Immune evasion mechanisms of human papillomavirus: An update.ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism.A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.Cervical Precancer Treatment in Low- and Middle-Income Countries: A Technology Overview.Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice.Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.A Targeted LC-MS Strategy for Low-Abundant HLA Class-I-Presented Peptide Detection Identifies Novel Human Papillomavirus T-Cell Epitopes.Activities of stromal and immune cells in HPV-related cancers.
P2860
Q35887553-AC8C38F5-6538-4BB7-B5F6-4FE63322B49BQ36022468-AB565675-5E06-49F0-8361-14DD1BC219D8Q36310924-A6A2F1CC-4A26-4500-AFAD-4E9268A74AD6Q36638606-93D9769F-4279-4425-AE0D-6ED78C2B433DQ37135023-BED91FE0-9E20-4083-976F-F97A3BA0C45EQ37592879-703FE212-E68D-423B-9E5B-63745B98B352Q37619549-F425C0DC-1129-4A61-9066-664367F2DDE0Q38807834-6E385A45-A8FC-42DE-8BDB-33753CB140B4Q40056541-0513C0C9-4795-464D-9DAB-E2BE7012773DQ40060642-A2DCA960-46CE-4E52-B05E-BBD576D4F2C9Q40091834-48370F6A-FA2C-49AF-A07B-354AC43F1A44Q40765193-FA521EB1-7D15-44E4-B181-004529E437A9Q41443004-6429B208-EB65-45AF-80FB-8C33FF35C8A2Q47775690-6165AC0A-EABA-4EC5-ABC6-85447CF50D21Q50115667-5A7DF56D-B392-4FF2-84A3-F4486510459BQ52617409-6C7F4266-EEA1-4652-9D98-4D33EEED470CQ55507801-B3E9AE4A-39D8-44CF-89C7-D3EEB75E87E4
P2860
Therapeutic Vaccine Strategies against Human Papillomavirus.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Therapeutic Vaccine Strategies against Human Papillomavirus.
@ast
Therapeutic Vaccine Strategies against Human Papillomavirus.
@en
type
label
Therapeutic Vaccine Strategies against Human Papillomavirus.
@ast
Therapeutic Vaccine Strategies against Human Papillomavirus.
@en
prefLabel
Therapeutic Vaccine Strategies against Human Papillomavirus.
@ast
Therapeutic Vaccine Strategies against Human Papillomavirus.
@en
P2860
P356
P1433
P1476
Therapeutic Vaccine Strategies against Human Papillomavirus.
@en
P2093
Agnieszka K Grabowska
Hadeel Khallouf
P2860
P304
P356
10.3390/VACCINES2020422
P577
2014-06-13T00:00:00Z